Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach

To validate cancer screening programs, experts recommend estimating effects on case fatality rates (CFRs) and cancer‐specific mortality. This study evaluates hepatocellular carcinoma (HCC) screening in patients with cirrhosis for those outcomes using a modeling approach. We designed a Markov model t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ningarhari, Massih, Mourad, Abbas, Delacôte, Claire, Ntandja Wandji, Line‐Carolle, Lassailly, Guillaume, Louvet, Alexandre, Dharancy, Sébastien, Mathurin, Philippe, Deuffic‐Burban, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512473/
https://www.ncbi.nlm.nih.gov/pubmed/36004703
http://dx.doi.org/10.1002/hep4.2059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512473/
https://www.ncbi.nlm.nih.gov/pubmed/36004703
http://dx.doi.org/10.1002/hep4.2059

Ejemplares similares